The University of Chicago Header Logo

Jessica Donington

Concepts (415)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
55
2023
1075
13.300
Why?
Lung Neoplasms
78
2023
2261
12.460
Why?
Pneumonectomy
23
2023
196
6.270
Why?
Neoplasm Staging
38
2023
1938
3.280
Why?
Thoracic Surgery
8
2022
41
3.230
Why?
Surgeons
6
2022
233
2.090
Why?
Osteopontin
6
2013
47
1.980
Why?
Radiosurgery
9
2021
272
1.760
Why?
Physicians, Women
5
2022
53
1.610
Why?
Thoracic Surgical Procedures
4
2022
44
1.590
Why?
Humans
131
2023
85777
1.500
Why?
Specialties, Surgical
2
2021
64
1.440
Why?
Thoracic Surgery, Video-Assisted
6
2022
30
1.380
Why?
Mesothelioma
14
2023
311
1.300
Why?
Adenocarcinoma
11
2016
1168
1.280
Why?
Early Detection of Cancer
4
2022
395
1.220
Why?
Pleural Neoplasms
11
2016
188
1.180
Why?
Small Cell Lung Carcinoma
4
2023
98
1.130
Why?
Esophagectomy
5
2009
84
1.100
Why?
Disease Management
3
2019
315
0.900
Why?
Catheter Ablation
6
2015
225
0.880
Why?
Neoadjuvant Therapy
7
2023
318
0.880
Why?
Chemotherapy, Adjuvant
6
2022
468
0.870
Why?
Jehovah's Witnesses
1
2022
18
0.870
Why?
Thymectomy
1
2022
31
0.860
Why?
Tomography, X-Ray Computed
11
2020
2583
0.860
Why?
Immunotherapy
6
2023
631
0.850
Why?
Radium
4
2023
7
0.820
Why?
Myasthenia Gravis
1
2022
83
0.820
Why?
Neoplasm Recurrence, Local
11
2023
1313
0.820
Why?
Biomarkers, Tumor
5
2021
1465
0.800
Why?
Symptom Assessment
1
2020
65
0.740
Why?
Antibody Formation
1
2020
171
0.730
Why?
Esophageal Neoplasms
4
2009
322
0.730
Why?
Antibodies, Viral
2
2021
299
0.720
Why?
Combined Modality Therapy
11
2022
1677
0.710
Why?
Societies, Medical
3
2020
539
0.700
Why?
Surgical Flaps
3
2017
241
0.700
Why?
Mass Screening
3
2022
601
0.690
Why?
Robotic Surgical Procedures
2
2022
268
0.670
Why?
Carcinoma, Squamous Cell
5
2016
1076
0.660
Why?
Treatment Outcome
14
2022
7830
0.650
Why?
Neoplasms, Second Primary
5
2016
252
0.630
Why?
Female
44
2023
44216
0.580
Why?
Probability
1
2017
352
0.580
Why?
Salvage Therapy
2
2017
233
0.570
Why?
Skin Ulcer
1
2016
25
0.570
Why?
Middle Aged
32
2023
24740
0.540
Why?
Hyaluronan Receptors
2
2013
36
0.540
Why?
Male
39
2023
40652
0.540
Why?
Frozen Sections
1
2015
48
0.530
Why?
Skin Transplantation
1
2016
172
0.530
Why?
Prognosis
16
2021
3639
0.530
Why?
Monitoring, Intraoperative
1
2015
109
0.510
Why?
Esophagus
2
2006
102
0.510
Why?
United States
14
2023
6580
0.500
Why?
Aged
26
2022
18161
0.480
Why?
Fluorodeoxyglucose F18
3
2012
138
0.480
Why?
Pancoast Syndrome
1
2013
2
0.470
Why?
Radiopharmaceuticals
3
2012
180
0.470
Why?
Fas Ligand Protein
1
2013
49
0.450
Why?
Adult
27
2022
25518
0.440
Why?
Positron-Emission Tomography
5
2013
329
0.430
Why?
Radiation Injuries
2
2010
156
0.410
Why?
Fluorine Radioisotopes
1
2012
25
0.410
Why?
Skin Neoplasms
1
2016
546
0.410
Why?
Cyclooxygenase 2
1
2012
99
0.410
Why?
Retrospective Studies
13
2023
8456
0.400
Why?
Neurosurgical Procedures
1
2013
212
0.400
Why?
Multimodal Imaging
1
2012
110
0.390
Why?
Bronchogenic Cyst
1
2010
5
0.390
Why?
Thoracic Wall
1
2010
21
0.380
Why?
Thoracic Diseases
1
2010
25
0.380
Why?
Soft Tissue Infections
1
2010
26
0.380
Why?
Clinical Trials as Topic
4
2020
1121
0.370
Why?
Risk Assessment
7
2022
2213
0.360
Why?
Survival Analysis
4
2019
1532
0.350
Why?
Simulation Training
2
2021
89
0.350
Why?
Radiotherapy, Adjuvant
3
2022
292
0.350
Why?
Education, Medical, Graduate
3
2020
373
0.350
Why?
Health Status Disparities
1
2011
170
0.330
Why?
Neoplasm Proteins
1
2012
534
0.320
Why?
Aged, 80 and over
15
2021
6479
0.300
Why?
Survival Rate
9
2021
1849
0.290
Why?
Dumping Syndrome
1
2006
5
0.280
Why?
Healthcare Disparities
1
2011
372
0.280
Why?
Gastric Emptying
1
2006
24
0.280
Why?
Protein Kinase Inhibitors
2
2022
590
0.270
Why?
Antineoplastic Agents
5
2020
2360
0.270
Why?
Stomach
1
2006
108
0.260
Why?
Transcription Factors
1
2013
1580
0.260
Why?
Esophageal Diseases
1
2005
26
0.260
Why?
Wounds, Nonpenetrating
1
2006
91
0.260
Why?
Patient Selection
3
2020
675
0.250
Why?
Pneumonia, Viral
2
2020
315
0.250
Why?
Coronavirus Infections
2
2020
300
0.250
Why?
Patient Care Management
2
2020
31
0.250
Why?
Consensus
3
2021
330
0.250
Why?
Risk Factors
5
2022
5249
0.250
Why?
Intubation, Intratracheal
1
2006
144
0.240
Why?
Deglutition Disorders
1
2006
115
0.240
Why?
General Surgery
1
2007
229
0.240
Why?
Computer Simulation
3
2021
1079
0.240
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2011
2438
0.240
Why?
Gastroesophageal Reflux
1
2006
117
0.240
Why?
Hamartoma
1
2003
31
0.230
Why?
Thymoma
1
2023
30
0.230
Why?
Antibodies, Neutralizing
2
2021
116
0.230
Why?
Thymus Neoplasms
1
2023
41
0.230
Why?
Negative-Pressure Wound Therapy
2
2014
10
0.220
Why?
Lymphatic Metastasis
4
2010
486
0.220
Why?
Medical Oncology
1
2007
360
0.220
Why?
Radiotherapy, Conformal
1
2023
83
0.220
Why?
Lung
4
2022
1170
0.220
Why?
Carcinoma, Bronchogenic
1
2002
30
0.220
Why?
Chylothorax
1
2022
7
0.220
Why?
Chylous Ascites
1
2022
9
0.220
Why?
Postoperative Complications
3
2022
2202
0.210
Why?
Neoplasm Metastasis
3
2019
1054
0.200
Why?
ErbB Receptors
2
2022
486
0.200
Why?
Loss of Function Mutation
1
2021
42
0.200
Why?
Steroids
1
2022
175
0.200
Why?
Funnel Chest
1
2021
8
0.200
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
104
0.200
Why?
Lung Diseases
1
2003
263
0.190
Why?
Chemoradiotherapy
2
2020
301
0.190
Why?
Pneumothorax
2
2020
53
0.190
Why?
Spike Glycoprotein, Coronavirus
1
2021
41
0.190
Why?
Immunization, Passive
1
2020
72
0.190
Why?
SEER Program
2
2011
190
0.180
Why?
Lung Transplantation
1
2022
176
0.180
Why?
Betacoronavirus
2
2020
257
0.180
Why?
Critical Pathways
1
2020
35
0.180
Why?
Pandemics
3
2021
737
0.180
Why?
Case-Control Studies
4
2013
1804
0.180
Why?
Sexual Harassment
1
2019
9
0.180
Why?
Career Choice
1
2021
141
0.180
Why?
Clinical Decision-Making
2
2019
256
0.170
Why?
Riots
1
2019
1
0.170
Why?
Protein Isoforms
2
2010
272
0.170
Why?
Drainage
1
2020
157
0.170
Why?
Randomized Controlled Trials as Topic
2
2020
812
0.170
Why?
Nontuberculous Mycobacteria
1
2018
9
0.170
Why?
Sexism
1
2019
51
0.170
Why?
Mycobacterium Infections, Nontuberculous
1
2018
24
0.160
Why?
Immunoglobulin G
1
2020
457
0.160
Why?
Thoracotomy
1
2018
58
0.160
Why?
Diagnosis, Differential
4
2013
1561
0.160
Why?
Periodicals as Topic
1
2020
165
0.160
Why?
Cohort Studies
5
2012
2738
0.160
Why?
Respiratory System
1
2018
116
0.160
Why?
Drug Resistance, Neoplasm
1
2021
592
0.160
Why?
Cost-Benefit Analysis
1
2020
451
0.150
Why?
Safety-net Providers
1
2018
37
0.150
Why?
Wound Closure Techniques
1
2017
14
0.150
Why?
Consolidation Chemotherapy
1
2017
22
0.150
Why?
Evidence-Based Medicine
2
2017
415
0.150
Why?
Thoracic Neoplasms
1
2017
64
0.150
Why?
Prosthesis-Related Infections
1
2017
58
0.140
Why?
Lymph Nodes
2
2011
533
0.140
Why?
Cell Proliferation
2
2013
1598
0.140
Why?
Meta-Analysis as Topic
4
2016
85
0.140
Why?
Asbestos
2
2012
22
0.130
Why?
National Cancer Institute (U.S.)
1
2015
70
0.130
Why?
Defibrillators, Implantable
1
2017
129
0.130
Why?
Forecasting
1
2016
301
0.130
Why?
Apoptosis
2
2013
1690
0.130
Why?
Surgical Wound Infection
1
2017
182
0.130
Why?
Biopsy
2
2016
1163
0.130
Why?
Subcutaneous Emphysema
1
2014
7
0.130
Why?
Photochemotherapy
1
1995
97
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
882
0.130
Why?
Simian virus 40
4
1998
35
0.120
Why?
Area Under Curve
2
2012
333
0.120
Why?
Prospective Studies
6
2023
4160
0.120
Why?
Radiography
2
2014
806
0.120
Why?
Liver Transplantation
1
2022
1271
0.120
Why?
Receptor, EphB2
1
2013
3
0.120
Why?
Neoplasm Invasiveness
2
2013
552
0.120
Why?
Peritoneum
1
2013
57
0.110
Why?
Snail Family Transcription Factors
1
2013
27
0.110
Why?
Neoplasm, Residual
2
2019
162
0.110
Why?
Operative Time
1
2013
126
0.110
Why?
Microbiota
1
2018
382
0.110
Why?
Clinical Protocols
1
2013
156
0.110
Why?
Surveys and Questionnaires
1
2021
2500
0.110
Why?
ROC Curve
2
2012
752
0.110
Why?
Blotting, Western
2
2013
787
0.110
Why?
Time-to-Treatment
1
2013
98
0.110
Why?
Epithelium
1
2013
319
0.110
Why?
Pain Management
1
2013
125
0.110
Why?
Biomarkers
2
2016
1697
0.100
Why?
Cytokines
3
2022
780
0.100
Why?
Extracellular Matrix Proteins
1
2012
124
0.100
Why?
Clinical Trials, Phase III as Topic
2
2007
170
0.100
Why?
Solitary Pulmonary Nodule
1
2013
138
0.100
Why?
Job Satisfaction
1
2012
73
0.100
Why?
Occupational Exposure
1
2012
79
0.100
Why?
Young Adult
5
2021
5961
0.100
Why?
Perfusion
2
2022
203
0.100
Why?
Palliative Care
1
2013
257
0.100
Why?
Radiotherapy, Computer-Assisted
1
2011
25
0.100
Why?
Carcinoma, Large Cell
1
2011
39
0.100
Why?
Sternoclavicular Joint
1
2010
2
0.100
Why?
Pulmonary Surgical Procedures
1
2010
8
0.100
Why?
Antibodies, Monoclonal
1
2017
1379
0.100
Why?
Colony-Forming Units Assay
1
2010
40
0.100
Why?
Mutation
1
2022
3978
0.100
Why?
Cranial Irradiation
2
2020
36
0.100
Why?
Cell Movement
2
2013
764
0.090
Why?
Ribonucleases
1
2011
92
0.090
Why?
Debridement
1
2010
56
0.090
Why?
Computer-Assisted Instruction
1
2011
43
0.090
Why?
Models, Anatomic
1
2011
90
0.090
Why?
Oligonucleotide Array Sequence Analysis
2
2010
692
0.090
Why?
Functional Laterality
1
2011
201
0.090
Why?
Tumor Cells, Cultured
3
2009
1041
0.090
Why?
Cell Line, Tumor
3
2011
2433
0.090
Why?
Models, Cardiovascular
1
2011
99
0.090
Why?
Tumor Burden
2
2011
290
0.090
Why?
Epithelial-Mesenchymal Transition
1
2010
76
0.090
Why?
Follow-Up Studies
4
2021
3591
0.090
Why?
Joint Diseases
1
2010
48
0.090
Why?
Necrosis
1
2010
204
0.090
Why?
Internship and Residency
1
2019
1011
0.090
Why?
Pain, Postoperative
1
2012
240
0.090
Why?
Tracheal Neoplasms
1
2009
8
0.090
Why?
Glomus Tumor
1
2009
8
0.090
Why?
Opioid-Related Disorders
1
2012
159
0.090
Why?
Chest Pain
1
2009
42
0.090
Why?
Sarcoidosis
1
2010
71
0.090
Why?
Cell Adhesion
1
2010
424
0.090
Why?
Endosonography
1
2010
96
0.080
Why?
Tuberculosis
1
2010
110
0.080
Why?
Minimally Invasive Surgical Procedures
1
2011
237
0.080
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
378
0.080
Why?
Time Factors
3
2012
5178
0.080
Why?
Length of Stay
2
2020
704
0.080
Why?
Mediastinal Neoplasms
2
2005
46
0.080
Why?
RNA, Messenger
2
2013
1986
0.080
Why?
MicroRNAs
2
2011
535
0.080
Why?
Wound Healing
1
2010
345
0.080
Why?
Microwaves
1
2008
34
0.080
Why?
Radiation Oncologists
2
2018
13
0.080
Why?
Analgesics, Opioid
1
2012
412
0.080
Why?
Chest Tubes
2
2020
23
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
412
0.080
Why?
NF-kappa B
1
2011
447
0.080
Why?
Sex Factors
1
2011
1041
0.080
Why?
DNA, Viral
2
1998
265
0.080
Why?
Receptor, IGF Type 1
2
1998
44
0.070
Why?
Neovascularization, Pathologic
1
2009
358
0.070
Why?
Gene Expression Profiling
2
2010
1388
0.070
Why?
Diagnostic Imaging
1
2011
466
0.070
Why?
Pulmonary Ventilation
1
2006
32
0.070
Why?
Disease-Free Survival
2
2011
1202
0.070
Why?
Sialoglycoproteins
1
2006
31
0.070
Why?
Cognition
1
2011
570
0.070
Why?
Carbonic Anhydrases
1
2006
15
0.070
Why?
Sex Distribution
1
2006
170
0.070
Why?
Mediastinoscopy
1
2005
5
0.070
Why?
Thoracic Injuries
1
2006
32
0.070
Why?
History, 21st Century
2
2017
174
0.070
Why?
California
1
2006
137
0.070
Why?
Peritoneal Neoplasms
2
1998
177
0.070
Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.070
Why?
Radiotherapy Dosage
1
2006
468
0.070
Why?
Esophagoplasty
1
2005
10
0.070
Why?
Anesthetics
1
2005
48
0.060
Why?
Blood Loss, Surgical
1
2005
112
0.060
Why?
Risk
1
2006
657
0.060
Why?
Antigens, Neoplasm
1
2006
325
0.060
Why?
Adolescent
3
2021
8959
0.060
Why?
Incidence
2
2022
1543
0.060
Why?
DNA Helicases
1
2023
82
0.060
Why?
Preoperative Care
1
2005
397
0.050
Why?
Proto-Oncogene Proteins c-ret
1
2022
21
0.050
Why?
Work-Life Balance
1
2022
6
0.050
Why?
Smoking
1
2006
604
0.050
Why?
Organ Preservation
1
2022
83
0.050
Why?
Asthma
1
2009
955
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2023
306
0.050
Why?
Hospital Mortality
1
2003
350
0.050
Why?
Transfection
3
2011
899
0.050
Why?
Leukocytes
1
2022
202
0.050
Why?
Cross Reactions
1
2021
109
0.050
Why?
Oxygen
1
2006
724
0.050
Why?
Clinical Competence
2
2020
756
0.050
Why?
Antigens, Viral
1
2021
144
0.050
Why?
Practice Guidelines as Topic
2
2018
992
0.050
Why?
Immunity, Humoral
1
2021
67
0.050
Why?
Epitopes
1
2021
255
0.050
Why?
Bioethics
1
2020
35
0.050
Why?
Child
2
2022
6930
0.050
Why?
Risk Management
1
2020
42
0.050
Why?
Etoposide
1
2020
196
0.050
Why?
Bias
1
2020
127
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2023
456
0.040
Why?
Margins of Excision
1
2019
39
0.040
Why?
Survivors
1
2021
227
0.040
Why?
Phosphoproteins
1
2021
255
0.040
Why?
Asbestosis
2
1998
5
0.040
Why?
Interdisciplinary Communication
1
2020
129
0.040
Why?
Medicare
1
2022
408
0.040
Why?
Tissue Donors
1
2022
465
0.040
Why?
Living Donors
1
2022
339
0.040
Why?
Infection Control
1
2020
115
0.040
Why?
Sputum
1
2018
34
0.040
Why?
Electrocardiography
1
2021
477
0.040
Why?
Bronchoalveolar Lavage Fluid
1
2018
121
0.040
Why?
Tumor Virus Infections
1
1998
81
0.040
Why?
Oligonucleotides, Antisense
1
1998
68
0.040
Why?
Regulatory Sequences, Nucleic Acid
1
1998
148
0.040
Why?
Self Report
1
2019
288
0.040
Why?
Genomics
1
2023
720
0.040
Why?
RNA, Ribosomal, 16S
1
2018
241
0.040
Why?
Heart
1
2021
556
0.040
Why?
Pilot Projects
2
2012
832
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
154
0.040
Why?
Liver
1
2022
1229
0.040
Why?
RNA, Antisense
1
1996
15
0.040
Why?
Feasibility Studies
2
1996
751
0.040
Why?
Sensitivity and Specificity
2
2012
1989
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
18
0.040
Why?
Comorbidity
1
2020
912
0.040
Why?
Receptor, ErbB-2
1
2018
224
0.030
Why?
Protein-Tyrosine Kinases
1
2018
302
0.030
Why?
Proto-Oncogene Proteins c-met
1
2018
199
0.030
Why?
B-Lymphocytes
1
2021
726
0.030
Why?
Anniversaries and Special Events
1
2016
14
0.030
Why?
Heart Ventricles
1
2021
764
0.030
Why?
Papillomavirus Infections
1
1998
239
0.030
Why?
Chromosome Disorders
1
1995
114
0.030
Why?
Radiation Oncology
1
2017
119
0.030
Why?
Genes, Tumor Suppressor
1
1995
157
0.030
Why?
Base Sequence
2
1996
2334
0.030
Why?
National Institutes of Health (U.S.)
1
1995
121
0.030
Why?
Clinical Trials, Phase II as Topic
1
1995
175
0.030
Why?
Clinical Trials, Phase I as Topic
1
1995
155
0.030
Why?
Genetic Predisposition to Disease
1
2023
2271
0.030
Why?
History, 20th Century
1
2016
310
0.030
Why?
Proto-Oncogene Proteins
1
2018
645
0.030
Why?
Molecular Sequence Data
2
1996
3034
0.030
Why?
Chromosome Aberrations
1
1995
387
0.030
Why?
Genetic Testing
1
2018
533
0.030
Why?
Immunohistochemistry
1
2018
1760
0.030
Why?
DNA Damage
1
1995
366
0.030
Why?
Genetic Therapy
1
1995
343
0.030
Why?
Immunoenzyme Techniques
1
2013
303
0.030
Why?
Fluorescent Antibody Technique
1
2013
318
0.030
Why?
Cricetinae
3
1998
560
0.030
Why?
Pleural Effusion, Malignant
1
2012
15
0.030
Why?
Pleural Effusion
1
2012
46
0.030
Why?
Reactive Oxygen Species
1
1995
480
0.030
Why?
Tumor Necrosis Factor-alpha
1
1996
685
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
277
0.030
Why?
Fear
1
2012
77
0.030
Why?
Self Concept
1
2012
133
0.030
Why?
Recurrence
1
2014
1136
0.030
Why?
RNA, Small Interfering
1
2013
549
0.030
Why?
Thoracoscopes
1
2011
2
0.020
Why?
Radiography, Thoracic
1
2013
320
0.020
Why?
Surgical Staplers
1
2011
11
0.020
Why?
Taxoids
1
2011
129
0.020
Why?
Dissection
1
2011
42
0.020
Why?
Computer Graphics
1
2011
100
0.020
Why?
Community-Based Participatory Research
1
2010
35
0.020
Why?
Carboplatin
1
2011
286
0.020
Why?
Motor Skills
1
2011
71
0.020
Why?
Patient Positioning
1
2011
63
0.020
Why?
Kaplan-Meier Estimate
1
2012
850
0.020
Why?
Mediastinum
1
2010
46
0.020
Why?
Affect
1
2012
386
0.020
Why?
Multivariate Analysis
1
2012
985
0.020
Why?
Biopsy, Needle
1
2010
234
0.020
Why?
Down-Regulation
1
2011
508
0.020
Why?
Longitudinal Studies
1
2012
1015
0.020
Why?
Depression
1
2012
472
0.020
Why?
Empyema
1
2008
9
0.020
Why?
Cells, Cultured
1
2013
2836
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2006
1200
0.020
Why?
Insulin-Like Growth Factor I
2
1998
114
0.020
Why?
Plasmids
2
1998
292
0.020
Why?
Carbonic Anhydrase IX
1
2006
11
0.020
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
Why?
Regression Analysis
1
2007
593
0.020
Why?
Age Factors
1
2010
1828
0.020
Why?
Tracheal Diseases
1
2005
13
0.020
Why?
Lymphatic Diseases
1
2005
36
0.020
Why?
Polymerase Chain Reaction
2
1998
929
0.020
Why?
Predictive Value of Tests
1
2010
1655
0.020
Why?
Animals
4
1998
26650
0.020
Why?
Reproducibility of Results
1
2010
2702
0.010
Why?
Lymphoma, Non-Hodgkin
1
2005
261
0.010
Why?
Disease Progression
1
2007
1458
0.010
Why?
Gene Expression Regulation, Viral
1
1998
90
0.010
Why?
Virus Replication
1
1998
319
0.010
Why?
HSP70 Heat-Shock Proteins
1
1998
113
0.010
Why?
Oxygenators
1
1996
3
0.010
Why?
Carcinoma, Adenoid Cystic
1
1996
28
0.010
Why?
Sarcoma, Ewing
1
1996
42
0.010
Why?
Cardiac Output
1
1996
155
0.010
Why?
Hyperthermia, Induced
1
1996
73
0.010
Why?
Safety
1
1996
151
0.010
Why?
Cell Transformation, Neoplastic
1
1998
428
0.010
Why?
Cell Division
1
1996
693
0.010
Why?
Remission Induction
1
1996
722
0.010
Why?
Sarcoma
1
1996
215
0.010
Why?
Pulmonary Artery
1
1996
307
0.010
Why?
Interferon-gamma
1
1996
445
0.010
Why?
Blood Pressure
1
1996
873
0.010
Why?
Melanoma
1
1996
459
0.010
Why?
Carcinoma, Renal Cell
1
1996
424
0.010
Why?
Transcription, Genetic
1
1996
1137
0.010
Why?
Rats
1
1996
3997
0.010
Why?
Donington's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (415)
Explore
_
Co-Authors (49)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_